Making sense of cancer genomic data.

@article{Chin2011MakingSO,
  title={Making sense of cancer genomic data.},
  author={Lynda Chin and William C. Hahn and Gad Getz and Matthew L Meyerson},
  journal={Genes \& development},
  year={2011},
  volume={25 6},
  pages={
          534-55
        }
}
High-throughput tools for nucleic acid characterization now provide the means to conduct comprehensive analyses of all somatic alterations in the cancer genomes. Both large-scale and focused efforts have identified new targets of translational potential. The deluge of information that emerges from these genome-scale investigations has stimulated a parallel development of new analytical frameworks and tools. The complexity of somatic genomic alterations in cancer genomes also requires the… 

Tables from this paper

Emerging patterns of somatic mutations in cancer

TLDR
The developing statistical approaches that are used to identify significantly mutated genes are highlighted, and the emerging biological and clinical insights from such analyses are discussed, as well as the future challenges of translating these genomic data into clinical impacts.

Proteogenomic Analysis of Single Amino Acid Polymorphisms in Cancer Research.

TLDR
This chapter describes a bioinformatics workflow for creating protein sequence databases and detecting mutated peptides in cancer samples from proteomic shotgun experiments, and has been evaluated using publicly available datasets from four cancer cell lines.

Oncogenomic portals for the visualization and analysis of genome-wide cancer data

TLDR
A highly illustrated review of seven web-based portals providing the visualization of small-size mutations, copy number variations, methylation, and gene/protein expression data that can be correlated with the available clinical, epidemiological, and molecular features of cancer molecular etiology.

Translating genomics to the clinic: implications of cancer heterogeneity.

TLDR
Only by adequately accounting for the underlying complexity of cancer genomes will the potential of genome sequencing be understood and subsequently translated into improved management of patients.

From human genome to cancer genome: the first decade.

TLDR
The key historical milestones in cancer genomics since the completion of the genome are reviewed, and some of the novel discoveries that are shaping the current understanding of cancer are reviewed.

Overview of Cancer Genomics, Organization, and Variations in the Human Genome

TLDR
The cost-effectiveness and labor intensity of techniques utilized for gene manipulations which advance the practices for biomedical and clinical diagnostics strategies are discussed.

Development of a tool for copy number analysis of cancer genomes using high throughput sequencing data

TLDR
A fast tool for the identification of CNAs and copy-neutral LOH in tumor samples using whole-genome sequencing data was developed and is fast and performs segmentation of a whole genome in less than two minutes.

What are we learning from the cancer genome?

TLDR
New features of cancer genomes that are being revealed by large-scale applications of massively parallel approaches to nucleic acid sequencing are reviewed, highlighting the formidable genetic heterogeneity within given cancer types that is appreciable with higher resolution profiling and larger sample sets.
...

References

SHOWING 1-10 OF 231 REFERENCES

Analysis of next-generation genomic data in cancer: accomplishments and challenges.

TLDR
The challenge will be to intelligently integrate data types and genomes to produce a coherent picture of the genetic basis of cancer.

Advances in understanding cancer genomes through second-generation sequencing

TLDR
This Review focuses on the methodological considerations for characterizing somatic genome alterations in cancer and the future prospects for these approaches.

Translating insights from the cancer genome into clinical practice

TLDR
Distinguishing between molecular abnormalities contribute to cancer and which are simply 'noise' at the genomic and epigenomic levels will aid in understanding how the aberrations in a cancer cell collaborate to drive pathophysiology.

Highly parallel identification of essential genes in cancer cells

TLDR
An efficient, robust approach to perform genome-scale pooled shRNA screens for both positive and negative selection and its application to systematically identify cell essential genes in 12 cancer cell lines is reported.

High-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray

TLDR
Using a commercially available 60-mer oligonucleotide microarray platform, it is demonstrated that this platform provides sufficient sensitivity to detect single-copy difference in gene dosage of full complexity genomic DNA while offering high resolution.

Somatic alterations in the human cancer genome.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

TLDR
It is found that pancreatic cancers contain an average of 63 genetic alterations, the majority of which are point mutations, which defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.

The genetics and genomics of cancer

TLDR
A deeper understanding of this disease will require new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

TLDR
The sequence of well-annotated human protein-coding genes in two common tumor types is determined to define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.

Characterizing the cancer genome in lung adenocarcinoma

TLDR
A large-scale project to characterize copy-number alterations in primary lung adenocarcinomas using dense single nucleotide polymorphism arrays identifies NKX2-1 (NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung carcinomas.
...